News

Published on 4 Feb 2023 on Simply Wall St. via Yahoo Finance

Novartis (VTX:NOVN) Is Paying Out A Larger Dividend Than Last Year


Article preview image

Novartis AG's (VTX:NOVN) dividend will be increasing from last year's payment of the same period to $3.20 on 13th of March. This will take the annual payment to 4.0% of the stock price, which is above what most companies in the industry pay.

See our latest analysis for Novartis

Novartis' Payment Has Solid Earnings Coverage

NYSE.NVS price evolution
SIX.NOVN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Tech advances are catalyzing the Health Care sector with improved investor sentiment -SSGA

The healthcare sector (XLV) has seen “the fruits of its labor” in higher earnings growth and help...

Seeking Alpha 19 Apr 2024

FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies

FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therap...

Benzinga via Yahoo Finance 19 Apr 2024

FDA requires changes to CAR-T cell therapy boxed warning (NYSE:BMY)

The FDA has mandated updates to safety information for CAR-T cell therapies due to a severe risk ...

Seeking Alpha 19 Apr 2024

9 Best Biotech ETFs for 2024

Biotechnology uses living organisms to develop new medicines and technologies that benefit both e...

GoBankingRates via AOL 19 Apr 2024

Novartis (NVS) Presents Positive Data on Rare Kidney Disease Drug

Novartis NVS presented encouraging results from a pre-specified interim analysis of the phase III...

Zacks via Yahoo Finance 16 Apr 2024

Looking for an Easy Way to Earn Passive Income? This Vanguard ETF Pays a Dividend Yield of Nearly...

There's a common problem with passive income: Generating it isn't as passive as investors expect....

Motley Fool via Yahoo Finance 14 Apr 2024

Novartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate

Novartis NVS entered into an exclusive strategic license agreement with a clinical-stage biotechn...

Zacks via Yahoo Finance 12 Apr 2024

Novartis (NVS) to Undertake Job Cuts in Development Department

Novartis NVS is set to reduce its workforce by 680, per a report by Reuters. It will do so in its...

Zacks via Yahoo Finance 11 Apr 2024

MorphoSys recommends shareholders to accept Novartis takeover offer By Investing.com

MorphoSys AG (FSE: MOR; NASDAQ: MOR) has recommended its shareholders to accept a takeover offer...

Investing.com 11 Apr 2024

Novartis commences tender offer for MorphoSys (NYSE:NVS)

Novartis has commenced its tender offer to acquire MorphoSys for €2.7B, offering a premium of 142...

Seeking Alpha 11 Apr 2024